Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2005
12/13/2005US6974864 Viral mucleotide sequences for use in the diagnosis and treatment of viral diseases
12/13/2005US6974791 These peptides possess a charge motif of positive-positive-hydrophobic which is important in determining the specificity of binding to tumor-derived endothelium.
12/13/2005US6974686 Recombinant tryptophan mutants of influenza
12/13/2005US6974668 antitumor agent binds to base DNA or RNA sequence; measure cytolysis of tumor cells; drug screening
12/13/2005US6974581 Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
12/13/2005US6974578 for relieving pain associated with muscle contractions and cholinergic controlled secretions including excessive sweating
12/13/2005US6974577 Inactivated bovine scours vaccines, processes and method of preventing bovine scours
12/13/2005US6974576 Extracts provided by the present invention have a higher immune stimulatory activity than extracts prepared and used in the art
12/13/2005US6974575 Generation of type I/type II hybrid form of bovine viral diarrhea virus for use as vaccine
12/13/2005US6974574 Tat/rev/vpr/nef genes/proteins for vaccines
12/13/2005US6974572 Peptide for use in the treatment of allergic disorders
12/13/2005CA2324403C Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
12/13/2005CA2001328C Borrelia antigen
12/11/2005CA2467769A1 Methods and formulations for testosterone suppression
12/08/2005WO2005116655A2 Natriuretic compounds, conjugates, and uses thereof
12/08/2005WO2005116270A2 Influenza virus vaccine composition and method of use
12/08/2005WO2005116260A2 Influenza hemagglutinin and neuraminidase variants
12/08/2005WO2005116258A2 Influenza hemagglutinin and neuraminidase varians
12/08/2005WO2005116218A1 Fusion gene of hepatitis b surface antigen with carboxyl end having pres2 immune determinant and the protein thereof
12/08/2005WO2005116216A1 Oral vaccine against protozoiasis using genetically modified plant
12/08/2005WO2005116077A2 LIGANDS BINDING THE COMPLEX OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (uPA) AND ITS RECEPTOR (uPAR) THAT INHIBIT DOWNSTREAM uPAR INTERACTIONS: IDENTIFICATION AND USE IN DIAGNOSIS OR THERAPY
12/08/2005WO2005116072A2 Antibodies as t cell receptor mimics, methods of production and uses thereof
12/08/2005WO2005116064A2 Altered fibronectin-binding protein of staphylococcus aureus
12/08/2005WO2005116062A1 Products and uses thereof
12/08/2005WO2005116056A1 Hla-a24- or hla-a2-binding peptide of parathyroid hormone-related protein
12/08/2005WO2005115483A1 Assay for transmissible spongiform encephalopathies
12/08/2005WO2005115480A2 Modified protein kinase a-specific oligonucleotides and methods of their use
12/08/2005WO2005115477A2 Non-natural ribonuclease conjugates as cytotoxic agents
12/08/2005WO2005115459A2 Anti-viral activity of an anti-thymidine kinase monoclonal antibody
12/08/2005WO2005115458A2 Methods and compositions related to regulation of nucleo-cytoplasmic localization of e1 dna helicase in papillomaviruses
12/08/2005WO2005115457A2 Combined active and passive targeting of biologically active agents
12/08/2005WO2005115456A2 METHODS OF MODULATING THE REPRODUCTIVE ENDOCRINE SYSTEM BY MODULATION OF TNFαACTIVITY
12/08/2005WO2005115455A2 Methods and reagents for the treatment of immunoinflammatory disorders
12/08/2005WO2005115454A2 Methods and compositions for cancer treatment relating to brca1 brct domain recognition of phosphorylated bach1
12/08/2005WO2005115453A2 Treatment of polychondritis and mononeuritis multiplex with anti-cd20 antibodies
12/08/2005WO2005115452A2 Fcϝriib-specific antibodies and methods of use thereof
12/08/2005WO2005115451A2 Methods for generating improved immune response
12/08/2005WO2005115450A1 Compositions comprising demethylating agents as enhancers of immunotherapy for the treatment of chronic infections and neoplastic diseases and methods for treating the same
12/08/2005WO2005115449A1 Method of treating allergy and infection by eliciting an iga antibody response
12/08/2005WO2005115448A2 Multi plasmid system for the production of influenza virus
12/08/2005WO2005115447A2 Human anti-cancer immunotherapy
12/08/2005WO2005115436A1 Soluble lfa-3 polypeptide for treating viral disorders
12/08/2005WO2005115419A1 USES OF BISPECIFIC ANTIBODY (Biab) COATED DENDRITIC CELLS PULSED WITH ANTIGENS
12/08/2005WO2005115412A2 Compositions and methods for modulating an immune response
12/08/2005WO2005115113A2 Polypeptides for inducing a protective immune response against staphylococcus aureus
12/08/2005WO2005092374A3 Recombinant herpes simplex virus and uses therefor
12/08/2005WO2005087261A3 Identification of self and non-self antigens implicated in autoimmune diseases
12/08/2005WO2005078075A3 Hybrid proteins of active-site serine beta-lactamase
12/08/2005WO2005077412A3 Compositions and methods of use of w-peptides
12/08/2005WO2005077018A3 Methods of treating skin disorders
12/08/2005WO2005075679A3 Antigenic hiv-1 peptides
12/08/2005WO2005074973A3 Method of inducing or modulating immune response
12/08/2005WO2005058234A3 Methods and compositions relating to ccr5 antagonist, ifn-ϝ and il-13 induced inflammation
12/08/2005WO2005052126A3 Biologically active antibodies recognizing a cell surface molecule selectively expressed on living mouse natural type one (i) interferon producing cells
12/08/2005WO2005011580A3 Compositions and methods for herpes simplex prophylaxis and treatment
12/08/2005WO2004069173A3 Methods for modulating an inflammatory response
12/08/2005WO2004050895A3 Methods and compositions for inducing apoptosis in cancer cells
12/08/2005WO2003104263A3 Cytokines and cytokine receptors with reduced immunogenicity
12/08/2005US20050272916 Method of modulating the activity of functional immune molecules
12/08/2005US20050272815 Compounds and compositions for delivering active agents
12/08/2005US20050272798 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents
12/08/2005US20050272758 Antineoplastic combinations of CCI-779 and rituximab
12/08/2005US20050272737 Combined treatment with irinotecan and an epidermal growth factor receptor kinase inhibitor
12/08/2005US20050272684 Breast cancer resistance protein (BCRP) and the DNA which encodes it
12/08/2005US20050272633 Derivatives of the nf-kappab inducing enzyme, their preparation and use
12/08/2005US20050272128 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
12/08/2005US20050272120 Compositions and methods for the diagnosis and treatment of tumor
12/08/2005US20050272097 Methods and compositions for detecting and treating autoimmune diseases
12/08/2005US20050272091 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection
12/08/2005US20050272090 Nucleic acid binding of multi-zinc finger transcription factors
12/08/2005US20050272038 Compositions and methods for diagnosis and therapy of cancers
12/08/2005US20050272031 Viral variants and uses therefor
12/08/2005US20050272029 Hepatitis c viral-like particle purification
12/08/2005US20050271728 High molecular weight medicine-containing preparation in powder form for administration through mucosa
12/08/2005US20050271690 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
12/08/2005US20050271689 Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax
12/08/2005US20050271688 Modified vaccinia ankara virus variant
12/08/2005US20050271687 Retrovirus-like particles made non-infectious by a plurality of mutations
12/08/2005US20050271685 Cellular permissivity factor for viruses and uses thereof
12/08/2005US20050271684 Apparatus and method for transdermal delivery of multiple vaccines
12/08/2005US20050271683 Nucleic acid sequences encoding Ostertagia ostertagi proteins and parts of such nucleic acid sequences encode an immunogenic fragment of such proteins; for use in vaccines
12/08/2005US20050271682 Administering the chimeric protein, comprising at least a first and a second polypeptide, wherein the N-terminus of the chimeric protien comprises the first polypeptide, wherein the first polypeptide comprises Borrelia burgdorferi OspC and wherein second polypeptide comprises Borrelia burgdorferi OspA
12/08/2005US20050271681 Isolated FrpB nucleic acid molecule and vaccine
12/08/2005US20050271680 Using immunogenic proteins LigA and LigB from Leptospira in development of effective vaccines and antibodies; detection of pathogenic Leptospira infection in a mammal
12/08/2005US20050271679 Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens
12/08/2005US20050271678 Diagnostic compositions containing the polypeptide conjugated to a detectable label, such as radioisotopes, enzymes, fluorescent labels, antibody conjugates, or substrates
12/08/2005US20050271677 inhibiting Flavivirus infection by inhibiting the fusion between the virion envelope and a cell membrane; E1 envelope glycoprotein of hepaciviruses and E2 envelope glycoprotein of pestivirus have previously undescribed structures, truncated class II fusion proteins
12/08/2005US20050271676 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
12/08/2005US20050271675 Includes a hapten or an antigen covalently linked to a carrier; not reversible at physiological pH, and that do not require reduction with boron-hydride
12/08/2005US20050271674 Methods and compositions for modulating the immune system of animals
12/08/2005US20050271673 Trifunctional reagent for conjugation to a biomolecule
12/08/2005US20050271671 Anthracycline-antibody conjugates
12/08/2005US20050271670 Treatments for cancer
12/08/2005US20050271669 For therapy of proliferative disease
12/08/2005US20050271668 Janus family kinases and identification of immune modulators
12/08/2005US20050271667 Identification of a novel endothelial-derived gene EG-1
12/08/2005US20050271666 Regulation of human protein phosphatase IIc-like enzyme
12/08/2005US20050271665 Administering an anti-SDF-1 or anti-CXCR4 antibody or binding fragment
12/08/2005US20050271664 Antibodies for inhibiting blood coagulation and methods of use thereof
12/08/2005US20050271663 treating rheumatoid arthritis by using single domain antibody polypeptide construct that binds human TNF- alpha
1 ... 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 ... 1823